BLUE
JAjcst2d.bsky.social

Eli Lilly has launched Zepbound single-dose vials at half the price of other incretin medicines, expanding access to obesity treatment. This provides an affordable option for those needing to self-pay. jcst2d.com/index.php?vi...#Healthcare#Obesity#EliLilly#Zepbound#AffordableCare

Image of a Zepbound (tirzepatide) 2.5 mg/0.5 mL single-dose vial for subcutaneous injection. Photo courtesy of Eli Lilly.
0
Jjaker9.bsky.social

every time I see anything about EliLilly all I can think about is how a brave poster cost them millions of dollars man fuck those dumbasses lol

0
JAjcsanalytics.bsky.social

Explore the rapid growth of the GLP-1 RA market driven by Eli Lilly and Novo Nordisk. Learn about sales trends, market drivers, and future outlook for type 2 diabetes management. jcsanalytics.com/index.php/ar...#GLP-1Sales#Type2Diabetes#EliLilly#NovoNordisk

Modern medical conference room with attendees focused on a large display screen presenting GLP-1 RA sales trends. The screen shows detailed charts and graphs, while the room features sleek, contemporary furniture and bright, professional lighting, highlighting the high-tech atmosphere.
0
uniquitous.bsky.social

Well god damn, #elililly, you go and make an actual miracle weight loss drug that works, and then you fail to anticipate demand? What the actual fuck? Ramp up your goddamn production so I can get a prescription filled without missing my re-up date by a week.

0

Mit dem ersten Spatenstich in #Alzey#elililly

1